Search results
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 10 hours agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax. Shah Capital ...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 6 days agoIn the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 7 days agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming the Medical ...
Path to a better tuberculosis vaccine runs through Montana
Arizona Daily Sun· 1 day agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. Bacille ...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 5 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 5 days agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Q1 2024 Enovix Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoBefore we continue, let me kindly remind you that we released our first quarter 2024 shareholder letter after the market close today is available on our website at ir dot novavax< ...
The path to a better Tuberculosis vaccine runs through Montana
Daily Montanan via Yahoo News· 2 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...